Astrazeneca said human trials of the vaccine it is developing with Oxford University have showed promising results, while Synairgen revealed a potentially ‘game-changing’ treatment.
Drug duo Astrazeneca and Synairgen soar as Covid battle intensifies
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]